Skip to Main Content

Paper Details

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.
Open Forum Infect Dis
20
2021
Human, Human Immunodeficiency, Integrase, Obesity, People, cardiovascular disease, cholesterol, glucose, human immunodeficiency virus, hypertension, integrase, low-density lipoprotein cholesterol, metabolic syndrome, obesity, participants, people, women
Author NameAffiliation
Carl J FichtenbaumUniversity of Cincinnati
Judith S CurrierUniversity of California at Los Angeles
Judith S CurrierUniversity of California at Los Angeles
Pamela S DouglasDuke Clinical Research Institute, Duke University School of Medicine
Heather J RibaudoCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health
  • 1 - 5

Datasets

Release 1.2